CompoAtlas

Osteoben TM

Natural health product licensed in Canada

Licence holder
Designs for Health
NPN or DIN-HM
80051043
Status
Active licence
Licence date
22 May 2014
Revision date
13 January 2023
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

6.25 microgrammesNot calculated
Vitamine D

Source : Cholécalciférol

250 UINot calculated
Zinc

Source : Diglycinate de zinc

2 mgNot calculated
Magnésium

Source : Malate de dimagnésium

100 mgNot calculated
Vitamine K2

Source : Ménaquinone 7

12.5 microgrammesNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Femmes en postménopauseNot specified2 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

May reduce severe and frequent menopausal symptoms (such as hot flashed and /or night sweats). Helps in the development and maintenance of bones. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. A multi-vitamin/mineral supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80051043

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line